Researchers Identify Lipid Involved in Lymphomas Caused by Virus

A new paper is reporting that certain lipids contribute to the survival of lymphomas caused by viruses; and further, that a molecule under investigation inhibits the creation of those lipids.

According to senior author Christopher Parsons, MD, Director of the HIV Malignancies Program at LSU Health Sciences Center New Orleans, specialized fat (lipid) molecules called sphingolipids have an important part to play in allowing aggressive lymphomas caused by viruses to survive.

Furthermore, the research team may have found a potential therapy to inhibit the activity of these sphingolipids.

People infected with the HIV virus often develop primary effusion lymphoma, or PEL (because Kaposi’s sarcoma-associated herpesvirus actually causes PEL). PEL is an aggressive version of the most commonly diagnosed lymphoma, diffuse large B-cell lymphoma. Therefore researchers used that model.

They began by analyzing the role of sphingosine kinase (SK), an enzyme associated with the creation of sphingolipids in PEL tumors. These keep the tumor cells alive, so researchers began throwing a targeted treatment at it, one that selectively targets SK.

The treatment molecule, known as ABC294640 (Apogee Biotechnology Corporation), has demonstrated antitumor effects in kidney, prostate, and breast cancer cell lines. In the current study the molecule inhibited SK and also induced PEL cell death. It managed to do this selectively in those cancer cells that were infected by virus. It did not harm those cells not virus-infected.

Wrote Parsons:

Our research thus far indicates that this molecule is safe, with the potential to stand alone as a single, orally administered drug with no need to combine it with other toxic drugs now routinely used but which fail to work for many patients.

The study appears in the January 2014 issue of Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research.

Source: Molecular Cancer Therapeutics

More Articles

More Articles

The term NK T cell lymphoma refers to one of two subtypes of lymphoma that affect the NK (Natural Killer)...

Canine lymphoma is a fairly common cancer in American dogs. The most commonly seen lymphoma in America is a type called Lymphosarcoma, although...

Prednisone is a glucocorticosteroid (a steroid) used in the treatment of many types of cancers. It functions as an anti-inflammatory medicine that...

Marginal zone lymphomas (MZL) are indolent lymphomas that affect the B-cells. The...

Large Cell Lymphoma (LCL) is typically an aggressive (fast growing) cancer of either the B cell or T cell type. They are one of the most common...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A lymphoma prognosis varies greatly depending on the type of lymphoma. There are more than 35 types of lymphoma, including 5 types of...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

Often the one who makes the first diagnosis of Hodgkin's Lymphoma / Disease is the person affected. There are some...

Lymphedema is abnormal swelling due to the presence of excess lymphatic fluid within the tissues. This swelling occurs when the...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

Hodgkin's Disease—also referred to as Hodgkin's Lymphoma, these are the exact same diseases, just...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

Canine lymphoma, just like lymphoma in humans, can be separated into stages,...